Recently nanozymes have received more and more attention and have been applied in many fields. Recent advances of applications of nanozymes as therapies for various reactive oxygen species (ROS)-induced diseases are summarized in this account. For each case, the rational design strategies as well as various factors regulating the multiple enzyme-like activities, are also discussed. Perspectives and Challenges are also mentioned.
No takes yet. Share an insight, caveat, or question.
Jiabao Shi (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: